Paediatric porto‐sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences

In paediatrics, porto‐sinusoidal vascular disease (PSVD) is relatively unknown and probably underdiagnosed. We aimed to describe clinical phenotypes, histology and outcome of children diagnosed with PSVD.

[1]  C. Sempoux,et al.  Porto-sinusoidal vascular disorder. , 2022, Journal of hepatology.

[2]  R. Ceriani,et al.  High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels , 2022, Liver international : official journal of the International Association for the Study of the Liver.

[3]  H. Yoshiji,et al.  Baveno VII - Renewing consensus in portal hypertension. , 2021, Journal of hepatology.

[4]  O. Riggio,et al.  Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension , 2021, Hepatic medicine : evidence and research.

[5]  Hwajeong Lee,et al.  Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data , 2021, Gastroenterology research.

[6]  A. Chan.  Faculty Opinions recommendation of Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[7]  L. D’Antiga,et al.  Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[8]  V. Vilgrain,et al.  Porto-sinusoidal vascular disease: proposal and description of a novel entity. , 2019, The lancet. Gastroenterology & hepatology.

[9]  C. Sempoux,et al.  Histology of portal vascular changes associated with idiopathic non‐cirrhotic portal hypertension: nomenclature and definition , 2018, Histopathology.

[10]  D. Sacchi,et al.  Pathology of idiopathic non-cirrhotic portal hypertension , 2018, Virchows Archiv.

[11]  D. Valla,et al.  Mutations in the novel gene FOPV are associated with familial autosomal dominant and non‐familial obliterative portal venopathy , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[12]  U. Beuers,et al.  A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension. , 2016, Journal of hepatology.

[13]  L. Giacomelli,et al.  Obliterative portal venopathy without portal hypertension: an underestimated condition , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[14]  H. Gouya,et al.  Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus , 2016, Medicine.

[15]  F. Aminkeng.  DLL4 loss‐of‐function heterozygous mutations cause Adams–Oliver syndrome , 2015, Clinical Genetics.

[16]  M. Hashizume,et al.  Comprehensive Screening of Gene Function and Networks by DNA Microarray Analysis in Japanese Patients with Idiopathic Portal Hypertension , 2015, Mediators of inflammation.

[17]  E. Elias,et al.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options. , 2014, Journal of clinical and experimental hepatology.

[18]  D. Pariente,et al.  Obliterative portal venopathy: a study of 48 children. , 2014, The Journal of pediatrics.

[19]  A. Berzigotti,et al.  Idiopathic portal hypertension: Natural history and long‐term outcome , 2014, Hepatology.

[20]  M. Rugge,et al.  Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis , 2014, Gut.

[21]  V. Ertekin,et al.  Hepatoportal Sclerosis in Childhood: Descriptive Analysis of 12 Patients , 2013, Journal of Korean medical science.

[22]  R. Stucchi,et al.  Liver failure and the need for transplantation in 6 patients with hepatoportal sclerosis. , 2013, Transplantation proceedings.

[23]  D. Valla,et al.  Idiopathic noncirrhotic portal hypertension , 2011, Hepatology.

[24]  V. Paradis,et al.  Obliterative portal venopathy: portal hypertension is not always present at diagnosis. , 2011, Journal of hepatology.

[25]  J. C. Chan,et al.  Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[26]  Y. Chawla,et al.  Intrahepatic portal venopathy and related disorders of the liver. , 2008, Seminars in liver disease.

[27]  T. Schiano,et al.  Liver Failure and Need for Liver Transplantation in Patients With Advanced Hepatoportal Sclerosis , 2007, The American journal of surgical pathology.

[28]  A. Dieux-Coeslier,et al.  Association of Adams–Oliver syndrome and hepatoportal sclerosis: An additional case , 2006, American journal of medical genetics. Part A.

[29]  H. Saisho,et al.  Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[30]  A. Krasinskas,et al.  Liver transplantation for severe intrahepatic noncirrhotic portal hypertension , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  S. Lyonnet,et al.  Adams–Oliver syndrome and hepatoportal sclerosis: Occasional association or common mechanism? , 2005, American journal of medical genetics. Part A.

[32]  E. Campbell,et al.  Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody , 2004, Gut.

[33]  D. Valla,et al.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients , 2002, Gut.

[34]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. , 2000 .

[35]  Y. Nakanuma,et al.  Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. , 1993, Hepato-gastroenterology.

[36]  J. Boitnott,et al.  Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy , 1990, Hepatology.

[37]  I. Wanless.  micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules , 1990, Hepatology.

[38]  N. Nayak.  Idiopathic portal hypertension (noncirrhotic portal fibrosis), thrombosis in portal venous system and protein C deficiency to the editor , 1989, Hepatology.

[39]  M. Ziol,et al.  Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. , 2008, Journal of hepatology.

[40]  R. Schreiber,et al.  Vascular abnormalities in Adams-Oliver syndrome: cause or effect? , 1999, American journal of medical genetics.

[41]  B. le Bail,et al.  Hepatoportal sclerosis. , 1995, Seminars in liver disease.

[42]  N. I. Radzhabova.  [Hepatoportal sclerosis]. , 1986, Sovetskaia meditsina.

[43]  R. AlvesJde.  [PORTAL HYPERTENSION]. , 1963, Hospital.